Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy. [PDF]
Eur Heart J Qual Care Clin OutcomesEngebretsen I +6 more
europepmc +1 more source
The Roles of PCSK9 in Alzheimer's Disease: A Systematic Review of Clinical, Genetic, and Preclinical Evidence. [PDF]
Life (Basel)Suswidiantoro V +5 more
europepmc +1 more source
Cholesterol-modulating effects of Korean red ginseng (KRG) targeting PCSK9 in hyperlipidemia [PDF]
Chang‐Hwan Lee +6 more
openalex +1 more source
Blocking PCSK9 suppresses hepatocellular carcinoma immune escape by decreasing FLI1-mediated SPP1 and PD-L1 expression. [PDF]
J Immunother CancerHu C +12 more
europepmc +1 more source
PCSK9 with a gain of function D374Y mutation aggravates atherosclerosis by inhibiting PPARα expression [PDF]
Yan Cui +6 more
openalex +1 more source
Association of PCSK9 Loss-of-Function Variants With Risk of Heart Failure
, 2022 Linea C. Trudsø +4 more
openalex +2 more sources
Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress. [PDF]
CellsRen Z +6 more
europepmc +1 more source
Proprotein convertase subtilisin/kexin type 9 expression is transiently up-regulated in the acute period of myocardial infarction in rat [PDF]
, 2014 core +1 more source
A rare case of alirocumab (PCSK9 inhibitor)-associated acute interstitial nephritis [PDF]
Nazia Habib +4 more
openalex +1 more source
PCSK9 Inhibition: Does Lipoprotein Size Matter? [PDF]
, 2015 Karim Si‐Tayeb, Bertrand Cariou
openalex +1 more source